References
- Hammond G L, Pitt B R, Gilles C N. Pulmonary metabolic function can serve as a monitor for lung preservation. Heart Transplant. 1985; 4: 603
- Kontos G J, Jr., Brokon A M, Fonger J D. Improved myocardial and pulmonary preservation by metabolic substrate enhancement in the autoperfused working heart-lung preparation. Heart Transplant. 1985; 4: 602
- Bando K, Tago M, Teramoto S, Japan O. Prevention of free radical-induced myocardial injury by allopurinol. J Thorac Cardiovasc Surg. 1988; 95: 465–473
- Burton K P, McCord J M, Ghai G. Myocardial alterations due to free radical generation. Am J Physiol. 1984; 246: H776–H783
- DeWall R A, Vasko K A, Stanley E L, Kezdi P. Responses of the ischemic myocardium to allopurinol. Am Heart J. 1971; 82(3)362–370
- Stewart J R, Crute S L, Loughlin V, Hess M L, Greenfield L J. Prevention of free radical-induced myocardial reperfusion injury with allopurinol. J Thorac Cardiovasc Surg. 1985; 90: 68–72
- Myers C L, Weiss S J, Kirsh M M, Shlafer M. Involvement of hydrogen peroxide and hydroxyl radical in the “oxygen paradox”: reduction of creatine kinase release by catalase, allopurinol or deferoxamine, but not by superoxide dismutase. J Mol Cell Cardiol. 1985; 17: 675–684
- McCord J M. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med. 1985; 312(3)159–163
- Godin D V, Bhimji S, McNeill J H. Effects of allopurinol pretreatment on myocardial ultrastructure and arrhythmias following coronary artery occlusion and reperfusion. Virchows Arch [B] 1986; 52: 327–341
- Godin D V, Bhimji S. Effects of allopurinol on myocardial ischemic injury induced by coronary artery ligation and reperfusion. Biochem Pharmacol. 1987; 36: 2101–2107
- Godin D V, Ko D M, Garnett M E. Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinol. Can J Cardiol. 1989; 5: 365–371
- Das D K, Englemen R M, Clement R, Otani H, Prasad M R, Rao P S. Role of xanthine oxidase inhibitors as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun. 1987; 148(1)314–319
- Muxfeldt M, Schaper W. The activity of xanthine oxidase in hearts of pigs, guinea pigs, rabbits and humans. Basic Res Cardiol. 1987; 82: 486–492
- Stocks J, Dormandy T L. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol. 1971; 20: 95–111
- Godin D V, Ko K M, Qayumi A K, Jamieson W RE. A method for monitoring the effectiveness of allopurinol pretreatment in the prevention of ischemic/reperfusion injury. J Pharmacol Methods. 1989; 22: 289–297
- Feeley T W, Mihm F G, Downing T P. Hypothermic preservation of the heart and lungs with Collin's solution: effect on cardiorespiratory function following heart-lung allotransplantation in dogs. Ann Thorac Surg. 1986; 41: 301–306
- Robicsek F, Masters T N, Duncan G D, Denyer M H, Rise H E, Etchison M. An autoperfused heart-lung preparation—metabolism and function. Heart Transplant. 1985; 4: 334–338
- Del Maestro R F, Bjork J, Arfors K E. Free radicals and microvascular permeability. Pathology of Oxygen, AP Autor. Academic, New York 1982; 157–172
- Eddy L J, Stewart J R, Jones H P, Engerson T D, McCord J M, Downey J M. Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol. 1987; 235: H709–H711
- Ko K M, Godin D V. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol. 1990; 40: 803–809